申请人:Roussel Uclaf
公开号:US05063225A1
公开(公告)日:1991-11-05
A compound selected from the group consisting of all possible isomeric forms, racemic or optically active of a compound of the formula ##STR1## wherein the substituents are defined in the specification, and their non-toxic, pharmaceutically acceptable acid addition salts having antiarhythmic activity.
从所有可能的同分异构体、消旋体或光学活性化合物中选择的一种化合物,其化学式为##STR1##,其中取代基在规范中定义,并且其无毒、药用可接受的酸盐具有抗心律失常活性。